Allergic conjunctivitis (AC) is an inflammation of the conjunctiva (a thin membrane covering the white part of the eye) due to allergy. It is often interchangeably known as Ocular Allergy; a common immunological hypersensitivity disorder.
Allergic Conjunctivitis can affect both children and adults, often coexisting with other allergic diseases such as asthma, atopic dermatitis or food allergy, though it is particularly associated with allergic rhinitis. Indeed, the term “rhinoconjunctivitis” is used in joint reference to both disorders, thereby complicating knowledge of each individual disease condition.
The diagnosis of ocular allergy is confirmed by a clinical history of typical eye symptoms, as well as in-vivo or in-vitro tests directed towards detecting free or cell-bound IgE.
Get FREE sample copy at:
The Allergic Conjunctivitis market report also covers emerging drugs, current treatment practices, Allergic Conjunctivitis market share of the individual therapies, current and forecasted Allergic Conjunctivitis Market Size from 2017 to 2030 segmented by seven major markets.
The report provides a detailed current Allergic Conjunctivitis treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Allergic Conjunctivitis Market Key Facts
In Italy, a cross-sectional study of randomly selected school children of 10-17-years-of-age in 2005–2006 determined the prevalence of rhinoconjunctivitis as 20.5% (DaiMiyazaki et al 2020).
Males are more affected as compared to females in the case of Allergic Conjunctivitis.
Older population studies estimate a prevalence of 15–20% of allergic conjunctivitis, but more recent studies implicate rates as high as 40%(Nelson et al.).
Atopic keratoconjunctivitis occurs predominantly between the late teenage years and fifth decade of life. It relapses and remits with no seasonal correlation. It is more frequent in men. Atopic dermatitis is present in 95% of cases and asthma in 87% of cases (Adrian Au, 2019).
Key Benefits of Allergic Conjunctivitis Market Report
Allergic Conjunctivitis market report provides an in-depth analysis of Allergic Conjunctivitis Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Allergic Conjunctivitis market report will help in developing business strategies by understanding the Allergic Conjunctivitis Market trends & developments, key players and future market competition that will shape and drive the Allergic Conjunctivitis market in the upcoming years.
The Allergic Conjunctivitis market report covers Allergic Conjunctivitis current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Allergic Conjunctivitis market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
Allergic Conjunctivitis Market
Allergic Conjunctivitis market size is expected to increase during the forecast period owing to the increasing number of patients suffering from this condition in the 7MM which would lead to higher adoption of therapeutic drugs in the forecasted period.
The Allergic Conjunctivitis market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Allergic Conjunctivitis market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Allergic Conjunctivitis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Allergic Conjunctivitis Epidemiology
The Allergic Conjunctivitis epidemiology section covers insights about historical and current Allergic Conjunctivitis patient pool and forecasted trends for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Allergic Conjunctivitis Drugs Uptake and Key Market Players
The Allergic Conjunctivitis Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Allergic Conjunctivitis market or expected to get launched in the market during the study period. The analysis covers Allergic Conjunctivitis market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Companies all over the globe are persistently working towards the development of new treatment therapies for Allergic Conjunctivitis. Some of the key players in the Allergic Conjunctivitis market at the global level include:
Nicox Ophthalmics Inc.
Allergic Conjunctivitis therapies covered in the report include:
And many more.
Table of Content
1. Key Insights
2. Executive Summary
3. Allergic Conjunctivitis Competitive Intelligence Analysis
4. Allergic Conjunctivitis Market Overview at a Glance
5. Allergic Conjunctivitis Disease Background and Overview
6. Allergic Conjunctivitis Patient Journey
7. Allergic Conjunctivitis Epidemiology and Patient Population
8. Allergic Conjunctivitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Allergic Conjunctivitis Unmet Needs
10. Key Endpoints of Allergic Conjunctivitis Treatment
11. Allergic Conjunctivitis Marketed Products
12. Allergic Conjunctivitis Emerging Therapies
13. Allergic Conjunctivitis Seven Major Market Analysis
14. Attribute Analysis
15. Allergic Conjunctivitis Market Outlook (7 major markets)
16. Allergic Conjunctivitis Access and Reimbursement Overview
17. KOL Views on the Allergic Conjunctivitis Market.
18. Allergic Conjunctivitis Market Drivers
19. Allergic Conjunctivitis Market Barriers
21. DelveInsight Capabilities
Allergic Conjunctivitis Epidemiology Forecast
DelveInsight’s Allergic Conjunctivitis – Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Allergic Conjunctivitis in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Allergic Conjunctivitis Pipeline Insights
Allergic Conjunctivitis Pipeline Insight, 2020 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allergic Conjunctivitis Market.
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd. 2432
City: Las Vegas
Country: United States